细胞学在原发性肺癌诊断中的研究进展

Recent development of cytology test in the diagnosis of primary lung cancer

目前,肺癌的发病率及病死率已跃居全球恶性肿瘤的首位,且早期诊断早期治疗已成为延长患者生存率的关键。细胞学检查在肺癌的诊断中占有极其重要的地位,而新兴的细胞学诊断技术及分子生物学的联合检测方法,可提高传统细胞学检查的敏感率,也为肺癌早期诊断的难题提供了可靠的解决途径。

At the present time, the morbidity and fatality rate of lung cancer is up-to the first place of malignant tumor all over the world. So the diagnosis of lung cancer is most important as early as possible. Cytology remains a high priority in the diagnosis of lung cancer. The associate technology of developing cytology and molecular biology, which advances the sensitivity of cytology, offers the settlement of early stage of lung cancer.